Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Incremental analysis showed that adding diet and exercise to UC resulted in an incremental cost-effectiveness ratio (ICER) of $25,400 per QALY, while the ICER associated with adding tirzepatide was $57,400 per QALY
It affects about 1 in 3 adults in the US 84 million people and about 70% will go on to be diagnosed with diabetes
of all taxes) 760 + 39 GST Check serviceability at your location
1 These numbers were not significantly different than patients in the placebo arm
In a fixed 1:1 blend the two move together, so the whole protocol is expressed as one 330 mcg total dose rather than two separate injections
6 The durability of this protection was reinforced in 2023 when a high-profile Inter Partes Review (IPR) challenge filed by Mylan (now Viatris) against the 343 patent failed
US$ 22.45
US$ 27.45
US$ 26.26
US$ 24.46
US$ 26.74
